Nrc Health (NRC) EBIT Margin (2010 - 2026)

Nrc Health (NRC) posted EBIT Margin of 16.0% for Q1 2026, up 20.62% sequentially from 13.27% in Q4 2025, and down 958.0% YoY from 1.86% in Q1 2025.

Nrc Health (NRC) EBIT Margin (2010 - 2026) Analysis & Trends

Nrc Health has reported EBIT Margin for 17 years, with the latest figure at 16.0% in Q1 2026.

Quarterly EBIT Margin fell 958.0% year-over-year to 16.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.11% (down 1067.0% YoY) and the FY2025 annual result came in at 16.44%, down 816.0% from the prior year.
EBIT Margin improved to 16.0% in Q1 2026 per NRC's latest filing, from 13.27% in the prior quarter.
Over five years, EBIT Margin peaked at 32.09% in Q4 2022 and troughed at 4.67% in Q2 2025.
A 5-year average of 24.16% and a median of 25.58% in 2025 frame the typical range for EBIT Margin.
The widest YoY moves for EBIT Margin: up 78 bps in 2025, down 2065 bps in 2025.
Over 5 years, EBIT Margin stood at 32.09% in 2022, then fell by 4 bps to 30.81% in 2023, then declined by 16 bps to 25.98% in 2024, then slumped by 49 bps to 13.27% in 2025, then increased by 21 bps to 16.0% in 2026.
According to Business Quant data, EBIT Margin over the past three periods registered 16.0%, 13.27%, and 22.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	30.93%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	3.37%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	29.03%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-12.95%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	19.00%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-11.11%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	23.79%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	21.48%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-27.93%
10	Nrc Health	469.13 Mn	465.81 Mn	21.84 Mn	-9.15%

Download Data